Reducing peripheral inflammation with infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy

Frontiers in Molecular Neuroscience

Volumn 9, Issue NOV2016, 2016, Pages

  Dadsetan, Sherry ^a   Balzano, Tiziano ^a   Forteza, Jerónimo ^b   Cabrera Pastor, Andrea ^a   Taoro Gonzalez, Lucas ^a   Hernandez Rabaza, Vicente ^a   Gil Perotín, Sara ^c   Cubas Núñez, Laura ^d   García Verdugo, José Manuel ^d   Agusti, Ana ^e   Llansola, Marta ^a   Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e Instituto Universitario IVI INCLIVA   (Spain)

Author keywords

Cognitive impairment; Hepatic encephalopathy; Neuroinflammation; Neurotransmission; TNF a

Indexed keywords

AMPA RECEPTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN E2; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AMMONIA BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATIC ENCEPHALOPATHY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MORRIS WATER MAZE TEST; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PORTOCAVAL SHUNT; PROTEIN EXPRESSION; RADIAL ARM MAZE TEST; RAT; SPATIAL LEARNING; WESTERN BLOTTING;

EID: 84995587982     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00106     Document Type: Article

References (49)

1. Agusti, A., Cauli, O., Rodrigo, R., Llansola,M., Hernández-Rabaza, V., and Felipo, V. (2011). p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 60, 1572-1579. doi: 10.1136/gut.2010.236083
2. Bajaj, J. S. (2008). Minimal hepatic encephalopathy matters in daily life. World J. Gastroenterol. 14, 3609-3615. doi: 10.3748/wjg.14.3609
3. Banks, W. A., Kastin, A. J., and Broadwell, R. D. (1995). Passage of cytokines across the blood-brain-barrier. Neuroimmunomodulation 2, 241-248. doi: 10.1159/000097202
4. Biesmans, S., Meert, T. F., Bouwknecht, J. A., Acton, P. D., Davoodi, N., De Haes, P., et al. (2013). Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediat. Inflamm. 2013: 271359. doi: 10.1155/2013/271359
5. Boudreau, A. C., and Wolf, M. E. (2005). Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J. Neurosci. 25, 9144-9151. doi: 10.1523/JNEUROSCI.2252-05.2005
6. Briscoe, T., Duncan, J., Cock, M., Choo, J., Rice, G., Harding, R., et al. (2006). Activation of NF-κB transcription factor in the preterm ovine brain and placenta after acute LPS exposure. J. Neurosci. Res. 83, 567-574. doi: 10.1002/jnr.20757
7. Brunner, P. M., Koszik, F., Reininger, B., Kalb, M. L., Bauer, W., and Stingl, G. (2013). Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages. J. Allergy Clin. Immunol. 132, 1184-1193. doi: 10.1016/j.jaci.2013.05.036
8. Butterworth, R. F., Norenberg, M. D., Felipo, V., Ferenci, P., Albrecht, J., Blei, A. T. et al. (2009). Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int. 29, 783-788. doi: 10.1111/j.1478-3231.2009.02034.x
9. Cagnin, A., Taylor-Robinson, S. D., Forton, D.M., and Banati, R. B. (2006). In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 55, 547-553. doi: 10.1136/gut.2005.075051
10. Cauli, O., Rodrigo, R., Piedrafita, B., Boix, J., and Felipo, V. (2007). Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with porto-caval shunts. Hepatology 46, 514-519. doi: 10.1002/hep.21734
11. Cheng, X., Shen, Y., and Li, R. (2014). Targeting TNF: a therapeutic strategy for Alzheimer’s disease. Drug Discov. Today 19, 1822-1827. doi: 10.1016/j.drudis.2014.06.029
12. D’Mello, C., Le, T., and Swain, M. G. (2009). Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor α signaling during peripheral organ inflammation. J. Neurosci. 29, 2089-2102. doi: 10.1523/JNEUROSCI.3567-08.2009
13. da Matta, S. M., Janaina Matos, M., Kummer, A. M., Barbosa, I. G., Teixeira, A. L., and Silva, A. C. (2014). Cognitive alterations in chronic kidney disease: an update. J. Bras. Nefrol. 36, 241-245. doi: 10.5935/0101-2800.20140035
14. Díaz-Gerevini, G. T., Repossi, G., Dain, A., Tarres, M. C., Das, U. N., and Eynard, A. R. (2014). Cognitive and motor perturbations in elderly with longstanding diabetes mellitus. Nutrition 30, 628-635. doi: 10.1016/j.nut.2013.11.007
15. Elfferich, M. D., Nelemans, P. J., Ponds, R. W., De Vries, J., Wijnen, P. A., and Drent, M. (2010). Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80, 212-219. doi: 10.1159/000314225
16. Felipo, V. (2013). Hepatic encephalopathy: effects of liver failure on brain function. Nat. Rev. Neurosci. 14, 851-858. doi: 10.1038/nrn3587
17. Felipo, V., Miñana,M. D., Azorín, I., and Grisolia, S. (1988). Induction of rat brain tubulin following ammonium ingestion. J. Neurochem. 51, 1041-1045.
18. Felipo, V., Ordoño, J. F., Urios, A., El Mlili, N., Giménez-Garzó, C., Aguado, C., et al. (2012a). Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 55, 530-539. doi: 10.1002/hep.24704
19. Felipo, V., Urios, A., Montesinos, E., Molina, I., Garcia-Torres, M. L., Civera, M., et al. (2012b). Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab. Brain Dis. 27, 51-58. doi: 10.1007/s11011-011-9269-3
20. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15, 193-204. doi: 10.1016/0896-6273(95)90076-4
21. Gimenez, M. A., Sim, J., Archambault, A. S., Klein, R. S., and Russell, J. H. (2006). A tumor necrosis factor receptor 1 dependent conversation between central nervous system specific t cells and the central nervous system is required for inflammatory infiltration of the spinal cord. Am. J. Pathol. 168, 1200-1209. doi: 10.2353/ajpath.2006.050332
22. Hang, C. H., Shi, J. X., Tian, J., Li, J. S., Wu, W., and Yin, H. X. (2004). Effect of systemic LPS injection on cortical NF-κB activity and inflammatory response following traumatic brain injury in rats. Brain Res. 1026, 23-32. doi: 10.1016/j.brainres.2004.07.090
23. Hernandez-Rabaza, V., Navarro-Mora, G., Velazquez-Sanchez, C., Ferragud, A., Marin, M. P., Garcia-Verdugo, J. M., et al. (2010). Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats. Addict. Biol. 15, 413-423. doi: 10.1111/j.1369-1600.2010.00259.x
24. Izadpanah, K., Freyer, D.,Weber, J. R., and Braun, J. S. (2014). Brain parenchymal TNF-α and IL-1β induction in experimental pneumococcal meningitis. J. Neuroimmunol. 276, 104-111. doi: 10.1016/j.jneuroim.2014.08.625
25. Karson, A., Demirtaş, T., Bayramgürler, D., Balci, F., and Utkan, T. (2013). Chronic administration of infliximab (TNF-a inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin. Pharmacol. Toxicol. 112, 335-340. doi: 10.1111/bcpt.12037
26. Kato, K., Fukunaga, K., Kamikozuru, K., Kashiwamura, S., Hida, N., Ohda, Y., et al. (2011). Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with crohn’s disease. Gut Liver 5, 37-45. doi: 10.5009/gnl.2011.5.1.37
27. Keifer, J., and Zheng, Z. (2010). AMPA receptor trafficking and learning. Eur. J. Neurosci. 32, 269-277. doi: 10.1111/j.1460-9568.2010.07339.x
28. Lai, A. Y., Swayze, R. D., El-Husseini, A., and Song, C. (2006). Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J. Neuroimmunol. 175, 97-106. doi: 10.1016/j.jneuroim.2006.03.001
29. Lee, S. H., and Fisher, B. (1961). Portocaval shunt in the rat. Surgery 50, 668-672.
30. Leevy, C. B., and Phillips, J. A. (2007). Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig. Dis. Sci. 52, 737-741. doi: 10.1007/s10620-006-9442-4
31. 2+ permeability of AMPARs at cerebellar synapses. Nat. Neurosci. 8, 768-775. doi: 10.1038/nn1468
32. Monfort, P., Erceg, S., Piedrafita, B., Llansola, M., and Felipo, V. (2007). Chronic liver failure impairs glutamatergic synaptic transmission and longterm potentiation in hippocampus and learning ability. Eur. J. Neurosci. 25, 2103-2111. doi: 10.1111/j.1460-9568.2007.05444.x
33. Montoliu, C., Piedrafita, B., Serra, M. A., del Olmo, J. A., Urios, A., Rodrigo, J. M., et al. (2009). IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J. Clin. Gastroenterol. 43, 272-279. doi: 10.1097/MCG.0b013e31815e7f58
34. Morris, R. G., and Frey, U. (1997). Hippocampal synaptic plasticity: role in spatial learning or the automatic recording of attended experience? Philos. Trans. R. Soc. Lond. B Biol. Sci. 352, 1489-1503. doi: 10.1098/rstb.1997.0136
35. Murta, V., Farías, M. I., Pitossi, F. J., and Ferrari, C. C. (2015). Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood-brain barrier integrity. J. Neuroimmunol. 278, 30-43. doi: 10.1016/j.jneuroim.2014.11.023
36. Nguyen, J. C., Killcross, A. S., and Jenkins, T. A. (2014). Obesity and cognitive decline: role of inflammation and vascular changes. Front. Neurosci. 8: 375. doi: 10.3389/fnins.2014.00375
37. 2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp. Neurol. 193, 384-393. doi: 10.1016/j.expneurol.2004.12.026
38. Raftery, G., He, J., Pearce, R., Birchall, D., Newton, J. L., Blamire, A. M., et al. (2012). Disease activity and cognition in rheumatoid arthritis: an open label pilot study. Arthritis Res. Ther. 14, R263. doi: 10.1186/ar4108
39. Rodrigo, R., Cauli, O., Gomez-Pinedo, U., Agusti, A., Hernandez-Rabaza, V., Garcia-Verdugo, J. M., et al. (2010). Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139, 675-684. doi: 10.1053/j.gastro.2010.03.040
40. Rummel, C., Sachot, C., Poole, S., and Luheshi, G. N. (2006). Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1316-R1326. doi: 10.1152/ajpregu.00301.2006
41. Sanderson, D. J., Good, M. A., Seeburg, P. H., Sprengel, R., Rawlins, J. N., and Bannerman, D. M. (2008). The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory. Prog. Brain Res. 169, 159-178. doi: 10.1016/S0079-6123(07)00009-X
42. Sanderson, D. J.,McHugh, S. B., Good,M. A., Sprengel, R., Seeburg, P. H., Rawlins, J. N., et al. (2010). Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner’s dual-process memory model. Neuropsychologia 48, 2303-2315. doi: 10.1016/j.neuropsychologia.2010.03.018
43. Shawcross, D. L., Davies, N. A., Williams, R., and Jalan, R. (2004). Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J. Hepatol. 40, 247-254. doi: 10.1016/j.jhep.2003.10.016
44. Shin, S. Y., Julian, L., and Katz, P. (2013). The relationship between cognitive function and physical function in rheumatoid arthritis. J. Rheumatol. 40, 236-243. doi: 10.3899/jrheum.120871
45. Stark, L. A., and Dunlop, M. G. (2005). Nucleolar sequestration of RelA (p65) regulates NF-κB-driven transcription and apoptosis. Mol. Cell. Biol. 25, 5985-6004. doi: 10.1128/MCB.25.14.5985-6004.2005
46. Tchélingérian, J. L., Le Saux, F., and Jacque, C. (1996). Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion. J. Neurosci. Res. 43, 99-106. doi: 10.1002/jnr.490430113
47. Umemura, T., Kawamura, T., Umegaki, H., Mashita, S., Kanai, A., Sakakibara, T., et al. (2011). Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 82, 1186-1194. doi: 10.1136/jnnp.2010.217380
48. Weissenborn, K., Giewekemeyer, K., Heidenreich, S., Bokemeyer, M., Berding, G., and Ahl, B. (2005). Attention, memory, and cognitive function in hepatic encephalopathy. Metab. Brain Dis. 20, 359-367. doi: 10.1007/s11011-005-7919-z
49. Wiltgen, B. J., Royle, G. A., Gray, E. E., Abdipranoto, A., Thangthaeng,N., Jacobs, N., et al. (2010). A role for calcium-permeable AMPA receptors in synaptic plasticity and learning. PLoS ONE 5: e12818. doi: 10.1371/journal.pone.0012818